Acquisition of Actis Generics Completed; Becomes Subsidiary
The acquisition of Actis Generics Private Limited is done.
By ScoutQuest · · 1 min read
- Transaction Type
- Acquisition of entire stake in Actis Generics Private Limited
- Acquirer
- RPG Active Pharma Limited (RPGAP)
- Share Purchase Agreement Date
- July 29, 2026
- Completion Date
- September 24, 2026
- Post-Acquisition Status
- Actis is a wholly owned subsidiary of RPGAP
What was shared
The company informed the exchanges that the transaction under the Share Purchase Agreement executed on July 29, 2026 has been completed.
Key points
- RPG Active Pharma Limited (RPGAP) acquired the entire stake of Actis Generics Private Limited.
- Completion date: September 24, 2026.
- From that date, Actis is a subsidiary of RPG Life Sciences and a wholly owned subsidiary of RPGAP.
How to read it
This is a closing intimation, confirming that a previously announced agreement has moved from signing to completion. It expands the group's subsidiary structure in the pharmaceutical space.
Also from RPG Life Sciences
RPG Life Sciences to hold Q2 FY27 results earnings call on October 30, 2026 at 5:00 PM IST
23 Oct 2026
Board Meeting on October 29, 2026 to Approve Q2 and H1 Results
23 Oct 2026
RPG Life Sciences Ltd shareholder buys 0.23% stake, holding rises to 7.04%
28 Sep 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.